A private board isn't a small public board
It sits closer to the founder, the cash and the next decision. Govern it like a FTSE board and you add drag the company can't afford.
Independent Chair · Board Director
I'm Willem Baralt, a Chair and Board Director with 25+ years of CEO, CFO and board experience across healthcare, medtech, AI enabled software and technology businesses in the US and Europe.
I take on a small number of chair and non-executive roles, plus selected advisory work through Light Beam Strategy, usually in cross-border, sponsor-backed companies that need investors and management aligned around strategy, risk and value.
It sits closer to the founder, the cash and the next decision. Govern it like a FTSE board and you add drag the company can't afford.
They need someone to ask the question everyone is avoiding — early, while it can still change the outcome, not in the post-mortem.
The hard part isn't the model. It's who owns the decision when the model is confidently wrong.
I've watched good products stall at reimbursement because the board treated it as a sales problem. It almost never is.
Where the work sits
LB Strategy concentrates where technical depth, regulation and capital collide — the sectors where board judgement is hardest and matters most.
MedTech
Evidence, regulation, reimbursement and adoption, weighed at board level.
Pharma & life sciences
Governing long horizons, trial risk and the economics of innovation.
AI in the boardroom
Model risk, accountability and data governance as board responsibilities.
European growth capital
Founder–investor alignment and governance through capital transitions.
Boardroom Notes
Practical notes for chairs, directors, founders and investors navigating governance, capital, AI, MedTech and private-company complexity.
Library
Books
A curated reading shelf across governance, capital, AI, MedTech, strategy, organisational behaviour and judgement.
Browse booksSources
Governance codes, institutional references, AI oversight sources, MedTech regulatory material and useful external resources.
Explore sourcesGet in touch
If you're a founder, investor or board facing a decision that matters, I'm happy to have a short, confidential conversation. I'd rather say no early than waste your time, so it's a genuine call, not a sales one.